{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:58:18Z","timestamp":1777903098880,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["085790\/Z\/08\/Z"],"award-info":[{"award-number":["085790\/Z\/08\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spirometric small airways obstruction (SAO) is common in the general population. Whether spirometric SAO is associated with respiratory symptoms,  cardiometabolic diseases, and quality of life (QoL) is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using data from the Burden of Obstructive Lung Disease study (N\u2009=\u200921,594), we defined spirometric SAO as the mean forced expiratory flow rate between 25 and 75% of the FVC (FEF<jats:sub>25-75<\/jats:sub>) less than the lower limit of normal (LLN) or the forced expiratory volume in 3\u00a0s to FVC ratio (FEV<jats:sub>3<\/jats:sub>\/FVC) less than the LLN. We analysed data on respiratory symptoms, cardiometabolic diseases, and QoL collected using standardised questionnaires. We assessed the associations with spirometric SAO using multivariable regression models, and pooled site estimates using random effects meta-analysis. We conducted identical analyses for isolated spirometric SAO (i.e. with FEV<jats:sub>1<\/jats:sub>\/FVC\u2009\u2265\u2009LLN).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Almost a fifth of the participants had spirometric SAO (19% for FEF<jats:sub>25-75<\/jats:sub>; 17% for FEV<jats:sub>3<\/jats:sub>\/FVC). Using FEF<jats:sub>25-75,<\/jats:sub> spirometric SAO was associated with dyspnoea (OR\u2009=\u20092.16, 95% CI 1.77\u20132.70), chronic cough (OR\u2009=\u20092.56, 95% CI 2.08\u20133.15), chronic phlegm (OR\u2009=\u20092.29, 95% CI 1.77\u20134.05), wheeze (OR\u2009=\u20092.87, 95% CI 2.50\u20133.40) and cardiovascular disease (OR\u2009=\u20091.30, 95% CI 1.11\u20131.52), but not hypertension or diabetes. Spirometric SAO was associated with worse physical and mental QoL. These associations were similar for FEV<jats:sub>3<\/jats:sub>\/FVC. Isolated spirometric SAO (10% for FEF<jats:sub>25-75<\/jats:sub>; 6% for FEV<jats:sub>3<\/jats:sub>\/FVC), was also associated with respiratory symptoms and cardiovascular disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Spirometric SAO is associated with respiratory symptoms, cardiovascular disease, and QoL. Consideration should be given to the measurement of FEF<jats:sub>25-75<\/jats:sub> and FEV<jats:sub>3<\/jats:sub>\/FVC, in addition to traditional spirometry parameters.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-023-02450-1","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:09:21Z","timestamp":1684861761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) study"],"prefix":"10.1186","volume":"24","author":[{"given":"Ben","family":"Knox-Brown","sequence":"first","affiliation":[]},{"given":"Jaymini","family":"Patel","sequence":"additional","affiliation":[]},{"given":"James","family":"Potts","sequence":"additional","affiliation":[]},{"given":"Rana","family":"Ahmed","sequence":"additional","affiliation":[]},{"given":"Althea","family":"Aquart-Stewart","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Barbara","sequence":"additional","affiliation":[]},{"given":"A. Sonia","family":"Buist","sequence":"additional","affiliation":[]},{"given":"Hamid Hacene","family":"Cherkaski","sequence":"additional","affiliation":[]},{"given":"Meriam","family":"Denguezli","sequence":"additional","affiliation":[]},{"given":"Mohammed","family":"Elbiaze","sequence":"additional","affiliation":[]},{"given":"Gregory E.","family":"Erhabor","sequence":"additional","affiliation":[]},{"given":"Frits M. E.","family":"Franssen","sequence":"additional","affiliation":[]},{"given":"Mohammed","family":"Al Ghobain","sequence":"additional","affiliation":[]},{"given":"Thorarinn","family":"Gislason","sequence":"additional","affiliation":[]},{"given":"Christer","family":"Janson","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Kocaba\u015f","sequence":"additional","affiliation":[]},{"given":"David","family":"Mannino","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Marks","sequence":"additional","affiliation":[]},{"given":"Kevin","family":"Mortimer","sequence":"additional","affiliation":[]},{"given":"Asaad Ahmed","family":"Nafees","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Obaseki","sequence":"additional","affiliation":[]},{"given":"Stefanni Nonna M.","family":"Paraguas","sequence":"additional","affiliation":[]},{"given":"Li Cher","family":"Loh","sequence":"additional","affiliation":[]},{"given":"Abdul","family":"Rashid","sequence":"additional","affiliation":[]},{"given":"Sundeep","family":"Salvi","sequence":"additional","affiliation":[]},{"given":"Terence","family":"Seemungal","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Studnicka","sequence":"additional","affiliation":[]},{"given":"Wan C.","family":"Tan","sequence":"additional","affiliation":[]},{"given":"Emiel F. M.","family":"Wouters","sequence":"additional","affiliation":[]},{"given":"Hazim","family":"Abozid","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Mueller","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Burney","sequence":"additional","affiliation":[]},{"given":"Andre F. S.","family":"Amaral","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"1","key":"2450_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12931-022-01990-2","volume":"23","author":"B Knox-Brown","year":"2022","unstructured":"Knox-Brown B, Mulhern O, Feary J, et al. Spirometry parameters used to define small airways obstruction in population-based studies: systematic review. Respir Res. 2022;23(1):67. https:\/\/doi.org\/10.1186\/s12931-022-01990-2.","journal-title":"Respir Res"},{"key":"2450_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01071-2020","author":"F Trinkmann","year":"2020","unstructured":"Trinkmann F, Watz H, Herth FJF. Why do we still cling to spirometry for assessing small airway function? Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.01071-2020.","journal-title":"Eur Respir J"},{"key":"2450_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-87553-3","volume-title":"Morphometry of the human lung","author":"ER Weibel","year":"1963","unstructured":"Weibel ER. Morphometry of the human lung. Saint Louis: Elsevier Science & Technology; 1963."},{"key":"2450_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00536-1","author":"M Kraft","year":"2022","unstructured":"Kraft M, Richardson M, Hallmark B, et al. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study. Lancet Respir Med. 2022. https:\/\/doi.org\/10.1016\/s2213-2600(21)00536-1.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2450_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000452479","volume":"93","author":"E Crisafulli","year":"2017","unstructured":"Crisafulli E, Pisi R, Aiello M, et al. Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration. 2017;93(1):32\u201341. https:\/\/doi.org\/10.1159\/000452479.","journal-title":"Respiration"},{"issue":"4","key":"2450_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10654-010-9435-7","volume":"25","author":"C Schneider","year":"2010","unstructured":"Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253\u201360. https:\/\/doi.org\/10.1007\/s10654-010-9435-7.","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"2450_CR7","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/s2213-2600(20)30155-7","volume":"8","author":"D Xiao","year":"2020","unstructured":"Xiao D, Chen Z, Wu S, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. Lancet Respir Med. 2020;8(11):1081\u201393. https:\/\/doi.org\/10.1016\/s2213-2600(20)30155-7.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2450_CR8","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/s2214-109x(22)00456-9","volume":"11","author":"B Knox-Brown","year":"2023","unstructured":"Knox-Brown B, Patel J, Potts J, et al. Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study. Lancet Glob Health. 2023;11(1):e69\u201382. https:\/\/doi.org\/10.1016\/s2214-109x(22)00456-9.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2450_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1378\/chest.12-2816","volume":"144","author":"ZQ Morris","year":"2013","unstructured":"Morris ZQ, Coz A, Starosta D. An isolated reduction of the FEV3\/FVC ratio is an indicator of mild lung injury. Chest. 2013;144(4):1117\u201323. https:\/\/doi.org\/10.1378\/chest.12-2816.","journal-title":"Chest"},{"key":"2450_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/copd.S295320","volume":"16","author":"S Qin","year":"2021","unstructured":"Qin S, Yu X, Ma Q, et al. Quantitative CT analysis of small airway remodeling in patients with chronic obstructive pulmonary disease by a new image post-processing system. Int J Chron Obstruct Pulmon Dis. 2021;16:535\u201344. https:\/\/doi.org\/10.2147\/copd.S295320.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"2450_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.chest.2016.06.047","volume":"150","author":"AG Dilektasli","year":"2016","unstructured":"Dilektasli AG, Porszasz J, Casaburi R, et al. A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest. 2016;150(5):1080\u201390. https:\/\/doi.org\/10.1016\/j.chest.2016.06.047.","journal-title":"Chest"},{"issue":"2","key":"2450_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.15326\/jcopdf.2021.0241","volume":"9","author":"BE Ronish","year":"2022","unstructured":"Ronish BE, Couper DJ, Barjaktarevic IZ, et al. Forced expiratory flow at 25%-75% Links COPD physiology to emphysema and disease severity in the SPIROMICS Cohort. Chronic Obstr Pulm Dis. 2022;9(2):111\u201321. https:\/\/doi.org\/10.15326\/jcopdf.2021.0241.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2450_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.10.046","author":"N Yee","year":"2021","unstructured":"Yee N, Markovic D, Buhr RG, et al. Significance of FEV(3)\/FEV(6) in recognition of early airway disease in smokers at risk of development of COPD: analysis of the SPIROMICS cohort. Chest. 2021. https:\/\/doi.org\/10.1016\/j.chest.2021.10.046.","journal-title":"Chest"},{"issue":"2","key":"2450_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1081\/COPD-57610","volume":"2","author":"AS Buist","year":"2005","unstructured":"Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD. 2005;2(2):277\u201383.","journal-title":"COPD"},{"issue":"3","key":"2450_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"American Thoracic Society","year":"1995","unstructured":"American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152(3):1107\u201336. https:\/\/doi.org\/10.1164\/ajrccm.152.3.7663792.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2450_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179\u201387. https:\/\/doi.org\/10.1164\/ajrccm.159.1.9712108.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2450_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1378\/chest.129.2.369","volume":"129","author":"JE Hansen","year":"2006","unstructured":"Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest. 2006;129(2):369\u201377. https:\/\/doi.org\/10.1378\/chest.129.2.369.","journal-title":"Chest"},{"issue":"11","key":"2450_CR18","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/s0895-4356(98)00109-7","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA. Project International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171\u20138. https:\/\/doi.org\/10.1016\/s0895-4356(98)00109-7.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2450_CR19","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1183\/09031936.00036813","volume":"43","author":"R Gr\u00f8nseth","year":"2014","unstructured":"Gr\u00f8nseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610\u201320. https:\/\/doi.org\/10.1183\/09031936.00036813.","journal-title":"Eur Respir J"},{"issue":"9","key":"2450_CR20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/01.cir.99.9.1165","volume":"99","author":"P Jousilahti","year":"1999","unstructured":"Jousilahti P, Vartiainen E, Tuomilehto J, et al. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99(9):1165\u201372. https:\/\/doi.org\/10.1161\/01.cir.99.9.1165.","journal-title":"Circulation"},{"issue":"4","key":"2450_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10900-011-9511-2","volume":"37","author":"KA Wickrama","year":"2012","unstructured":"Wickrama KA, O\u2019Neal CW, Lott RE. Early community contexts, race\/ethnicity and young adult CVD risk factors: the protective role of education. J Community Health. 2012;37(4):781\u201390. https:\/\/doi.org\/10.1007\/s10900-011-9511-2.","journal-title":"J Community Health"},{"issue":"1","key":"2450_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12931-022-01939-5","volume":"23","author":"K Kulbacka-Ortiz","year":"2022","unstructured":"Kulbacka-Ortiz K, Triest FJJ, Franssen FME, et al. Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study. Respir Res. 2022;23(1):34. https:\/\/doi.org\/10.1186\/s12931-022-01939-5.","journal-title":"Respir Res"},{"issue":"4","key":"2450_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/1468-2389.00156","volume":"8","author":"JE Hunter","year":"2000","unstructured":"Hunter JE, Schmidt FL. Fixed effects vs. random effects meta-analysis models: implications for cumulative research knowledge. Int J Select Assess. 2000;8(4):275\u201392. https:\/\/doi.org\/10.1111\/1468-2389.00156.","journal-title":"Int J Select Assess"},{"key":"2450_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00621-2017","author":"F Mejza","year":"2017","unstructured":"Mejza F, Gnatiuc L, Buist AS, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00621-2017.","journal-title":"Eur Respir J"},{"key":"2450_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2147\/jaa.S318502","volume":"14","author":"Y Kim","year":"2021","unstructured":"Kim Y, Lee H, Chung SJ, et al. The usefulness of FEF(25\u201375) in predicting airway hyperresponsiveness to Mannitol. J Asthma Allergy. 2021;14:1267\u201375. https:\/\/doi.org\/10.2147\/jaa.S318502.","journal-title":"J Asthma Allergy"},{"key":"2450_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00561-2019","author":"C Janson","year":"2019","unstructured":"Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00561-2019.","journal-title":"Eur Respir J"},{"issue":"2","key":"2450_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/15412555.2019.1614550","volume":"16","author":"FJJ Triest","year":"2019","unstructured":"Triest FJJ, Studnicka M, Franssen FME, et al. Airflow obstruction and cardio-metabolic comorbidities. COPD. 2019;16(2):109\u201317. https:\/\/doi.org\/10.1080\/15412555.2019.1614550.","journal-title":"COPD"},{"key":"2450_CR28","doi-asserted-by":"publisher","first-page":"106441","DOI":"10.1016\/j.rmed.2021.106441","volume":"184","author":"S Costanzo","year":"2021","unstructured":"Costanzo S, Magnacca S, Bonaccio M, et al. Reduced pulmonary function, low-grade inflammation and increased risk of total and cardiovascular mortality in a general adult population: prospective results from the Moli-sani study. Respir Med. 2021;184:106441. https:\/\/doi.org\/10.1016\/j.rmed.2021.106441.","journal-title":"Respir Med"},{"issue":"9709","key":"2450_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s0140-6736(09)61717-7","volume":"375","author":"S Kaptoge","year":"2010","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(09)61717-7.","journal-title":"Lancet"},{"issue":"6","key":"2450_CR30","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/hypertensionaha.111.186072","volume":"59","author":"Y Chen","year":"2012","unstructured":"Chen Y, Guo H, Xu D, et al. Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart failure causes severe lung disease. Hypertension. 2012;59(6):1170\u20138. https:\/\/doi.org\/10.1161\/hypertensionaha.111.186072.","journal-title":"Hypertension"},{"key":"2450_CR31","doi-asserted-by":"publisher","first-page":"5492680","DOI":"10.1155\/2018\/5492680","volume":"2018","author":"MM Birhan","year":"2018","unstructured":"Birhan MM, Abebe Y. Pulmonary function tests in hypertensive patients attending Zewditu Memorial Hospital, Addis Ababa, Ethiopia. Int J Hypertens. 2018;2018:5492680. https:\/\/doi.org\/10.1155\/2018\/5492680.","journal-title":"Int J Hypertens"},{"issue":"6","key":"2450_CR32","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3803\/EnM.2021.1249","volume":"36","author":"HY Lee","year":"2021","unstructured":"Lee HY, Shin J, Kim H, et al. Association between lung function and new-onset diabetes mellitus in healthy individuals after a 6-year follow-up. Endocrinol Metab (Seoul). 2021;36(6):1254\u201367. https:\/\/doi.org\/10.3803\/EnM.2021.1249.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"2450_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.arbres.2019.01.006","volume":"56","author":"C Garc\u00eda-Quero","year":"2020","unstructured":"Garc\u00eda-Quero C, Carreras J, Mart\u00ednez-Cer\u00f3n E, et al. Small airway dysfunction impairs quality of life among smokers with no airflow limitation. Arch Bronconeumol (Engl Ed). 2020;56(1):9\u201317. https:\/\/doi.org\/10.1016\/j.arbres.2019.01.006.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"issue":"6","key":"2450_CR34","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1183\/09031936.00153712","volume":"42","author":"C Janson","year":"2013","unstructured":"Janson C, Marks G, Buist S, et al. The impact of COPD on health status: findings from the BOLD study. Eur Respir J. 2013;42(6):1472\u201383. https:\/\/doi.org\/10.1183\/09031936.00153712.","journal-title":"Eur Respir J"},{"issue":"1","key":"2450_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1465-9921-14-103","volume":"14","author":"T Tilert","year":"2013","unstructured":"Tilert T, Dillon C, Paulose-Ram R, et al. Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007\u20132010. Respir Res. 2013;14(1):103. https:\/\/doi.org\/10.1186\/1465-9921-14-103.","journal-title":"Respir Res"},{"issue":"1","key":"2450_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12931-022-02194-4","volume":"23","author":"M Ekstr\u00f6m","year":"2022","unstructured":"Ekstr\u00f6m M, Mannino D. Research race-specific reference values and lung function impairment, breathlessness and prognosis: analysis of NHANES 2007\u20132012. Respir Res. 2022;23(1):271. https:\/\/doi.org\/10.1186\/s12931-022-02194-4.","journal-title":"Respir Res"},{"issue":"4","key":"2450_CR37","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1183\/09031936.00128113","volume":"43","author":"PH Quanjer","year":"2014","unstructured":"Quanjer PH, Weiner DJ, Pretto JJ, et al. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051\u20138. https:\/\/doi.org\/10.1183\/09031936.00128113.","journal-title":"Eur Respir J"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02450-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02450-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02450-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:11:01Z","timestamp":1684861861000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02450-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02450-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained by each site from the local ethics committee, all sites adhered to local ethics guidelines, and followed good clinical practice. Written Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Outside of the submitted work: DM declares being a consultant to GlaxoSmithKline, AstraZeneca, COPD Foundation. Royalties\u2014Up to Date. Expert Witness-Schlesinger Law Firm. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}